Literature DB >> 10424592

Ischemia-reperfusion lung injury is prevented by apocynin, a novel inhibitor of leukocyte NADPH oxidase.

D B Pearse1, J M Dodd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10424592     DOI： 10.1378/chest.116.suppl_1.55s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  8 in total

Review 1.  Sources and targets of reactive oxygen species in synaptic plasticity and memory.

Authors:  Kenneth T Kishida; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2007-02       Impact factor: 8.401

2.  NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.

Authors:  Ashish K Sharma; Damien J LaPar; Matthew L Stone; Yunge Zhao; Christopher K Mehta; Irving L Kron; Victor E Laubach
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

3.  NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.

Authors:  Zequan Yang; Ashish K Sharma; Melissa Marshall; Irving L Kron; Victor E Laubach
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

Review 4.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

Review 5.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

6.  NADPH oxidase mediates synergistic effects of IL-17 and TNF-α on CXCL1 expression by epithelial cells after lung ischemia-reperfusion.

Authors:  Ashish K Sharma; Daniel P Mulloy; Lamvy T Le; Victor E Laubach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-01       Impact factor: 5.464

7.  Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Tian Shen; Guoqiang Xing; Jingfen Zhu; Yong Cai; Shuxian Zhang; Gang Xu; Yi Feng; Donghua Li; Jianyu Rao; Rong Shi
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-14       Impact factor: 2.629

Review 8.  Apocynin: molecular aptitudes.

Authors:  J Stefanska; R Pawliczak
Journal:  Mediators Inflamm       Date:  2008-12-02       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.